Pediatric Nephrology Research Consortium is located in Columbus, OH. The organization was established in 2019. According to its NTEE Classification (G05) the organization is classified as: Research Institutes & Public Policy Analysis, under the broad grouping of Voluntary Health Associations & Medical Disciplines and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Pediatric Nephrology Research Consortium is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2022, Pediatric Nephrology Research Consortium generated $487.9k in total revenue. This organization has experienced exceptional growth, as over the past 4 years, it has increased revenue by an average of 49.4% each year . All expenses for the organization totaled $491.4k during the year ending 12/2022. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2022
Describe the Organization's Mission:
Part 3 - Line 1
THE PURPOSE IS TO FUNCTION AS A NON-PROFIT EDUCATIONAL, SCIENTIFIC AND RESERACH ORGANIZATION TO ENABLE AND ADVANCE PEDIATRIC CLINICAL RESEARCH BY DEVELOPING, ADVANCING, ACCUMULATING AND MAINTAINING SCIENTIFIC KNOWLEDGE REGARDING BEST PRACTICES AND STRATEGIES FOR THE CONDUCT OF PEDIATRIC NEPHROLOGY CLINICAL RESERACH AND TREATMENT OF CHILDREN. EDUCATING OUR MEMBERS AND OTHERS ABOUT THE BEST PRACTIES AND STRATEGIES IN PEDIATRIC NEPHROLOGY RESEARCH AND AIDING THEM ON OBTAINING HIGH-QUALITY DATA USEFUL FOR THE ADVANCEMENT OF SCIENTIFIC KNOWLEDGE. DISSEMINATING INFORMATION AND SCIENTIFIC RESEARCH TO AND FACILITATING COMMUNICATION AMONG, RESEARCHERS, CLINICAL RESEARCH SPONSORS, REGULATORS AND OTHER STAKEHOLDERS REGARDING BEST PRACTICES AND STRATEGIES FOR THE CONDUCT OF PEDIATRIC NEPHROLOGY CLINICAL RESEARCH.
Describe the Organization's Program Activity:
Part 3 - Line 4a
EDUCATING OUR MEMBERS AND OTHERS ABOUT THE BEST PRACTICES AND STRATEGIES IN PEDIATRIC NEPHROLOGY RESEARCH AND AIDING THEM IN OBTAINING HIGH-QUALITY DATA USEFUL FOR THE ADVANCEMENT OF SCIENTIFIC KNOWLEDGE. DISSEMINATING INFORMATION AND SCIENTIFIC RESEARCH TO,AND FACILITATING COMMUMICATION AMONG, RESEARCHERS, CLINICAL RESEARCH SPONSORS, REGULATORS AND OTHER STAKEHOLDERS REGARDING THE BEST PRACTICES AND STRATEGIES FOR THE CONDUCT OF PEDIATRIC NEPHROLOGY CLINICAL RESEARCH AT OUR CONFERENCES. THE PNRC WILL HOLD 1 TO 2 IN-PERSON CONFERENCES OR VIRTUAL CONFERENCES (WHEN AN IN-PERSON CONFERENCE CANNOT BE ACCOMMODATED) TO FACILITATE THE SHARING OF KNOWLEDGE, THE DEVELOPMENT OF NEW KNOWLEDGE AND EDUCATION PERTAINING TO NEPHROLOGY RESEARCH.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
John D Mahan MD President | OfficerTrustee | 5 | $0 |
Tej Mattoo MD Treasurer | OfficerTrustee | 5 | $0 |
Michelle Rheault MD Director | Trustee | 1 | $0 |
Myda Khalid MD Director | Trustee | 1 | $0 |
Priya Verghese MD Director | Trustee | 1 | $0 |
William E Smoyer MD Director | Trustee | 1 | $0 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $0 |
Fundraising events | $0 |
Related organizations | $0 |
Government grants | $0 |
All other contributions, gifts, grants, and similar amounts not included above | $305,000 |
Noncash contributions included in lines 1a–1f | $0 |
Total Revenue from Contributions, Gifts, Grants & Similar | $305,000 |
Total Program Service Revenue | $182,928 |
Investment income | $0 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | $0 |
Net Income from Fundraising Events | $0 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $487,928 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $165,974 |
Grants and other assistance to domestic individuals. | $0 |
Grants and other assistance to Foreign Orgs/Individuals | $105,000 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $0 |
Compensation of current officers, directors, key employees. | $0 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $0 |
Pension plan accruals and contributions | $0 |
Other employee benefits | $0 |
Payroll taxes | $0 |
Fees for services: Management | $90,054 |
Fees for services: Legal | $7,934 |
Fees for services: Accounting | $3,395 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $0 |
Fees for services: Other | $0 |
Advertising and promotion | $0 |
Office expenses | $5,928 |
Information technology | $6,978 |
Royalties | $0 |
Occupancy | $0 |
Travel | $3,600 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $79,616 |
Interest | $0 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $0 |
Insurance | $5,213 |
All other expenses | $2,634 |
Total functional expenses | $491,394 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $198,979 |
Savings and temporary cash investments | $0 |
Pledges and grants receivable | $0 |
Accounts receivable, net | $0 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $0 |
Net Land, buildings, and equipment | $0 |
Investments—publicly traded securities | $0 |
Investments—other securities | $0 |
Investments—program-related | $0 |
Intangible assets | $0 |
Other assets | $0 |
Total assets | $198,979 |
Accounts payable and accrued expenses | $0 |
Grants payable | $0 |
Deferred revenue | $0 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $0 |
Total liabilities | $0 |
Net assets without donor restrictions | $198,979 |
Net assets with donor restrictions | $0 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $198,979 |
Over the last fiscal year, Pediatric Nephrology Research Consortium has awarded $165,974 in support to 5 organizations.
Grant Recipient | Amount |
---|---|
DUKE NEPHROLOGY CLINIC | | | $70,000 |
CHILDREN'S MERCY HOSPITAL RESEARCHINSTITUTE | | | $55,545 |
Kansas City, MO | | $24,129 |
UNIVERSITY OF COLORADO DENVER | | | $10,000 |
Atlanta, GA | | $6,300 |
Organization Name | Assets | Revenue |
---|---|---|
Ecog-Acrin Medical Research Foundation Inc Philadelphia, PA | $11,624,125 | $49,270,427 |
Pediatric Nephrology Research Consortium Columbus, OH | $198,979 | $487,928 |
Diabetes Patient Advocacy Coalition Lexington, KY | $840,273 | $540,959 |
Integrative Medicine Foundation Inc Cincinnati, OH | $438,389 | $35,157 |
Multiple Sclerosis Research Institute Philadelphia, PA | $453,092 | $0 |
Boilermaker Health Innovations Inc West Lafayette, IN | $1,023,120 | $142,641 |